161 related articles for article (PubMed ID: 1975446)
1. Effects of antihistaminics on naloxone-induced withdrawal in morphine-dependent mice.
Leza JC; Lizasoain I; Lorenzo P
Psychopharmacology (Berl); 1990; 102(1):106-11. PubMed ID: 1975446
[TBL] [Abstract][Full Text] [Related]
2. H1- and H2-histamine receptor blockers and opiate analgesia in mice.
Leza JC; Lizasoain I; Lorenzo P
Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):671-8. PubMed ID: 1983158
[TBL] [Abstract][Full Text] [Related]
3. The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice.
el Kadi AO; Sharif SI
Pharmacol Biochem Behav; 1996 Sep; 55(1):49-54. PubMed ID: 8870037
[TBL] [Abstract][Full Text] [Related]
4. Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity.
Leza JC; Lizasoain I; Lorenzo P
Gen Pharmacol; 1991; 22(2):293-6. PubMed ID: 1676005
[TBL] [Abstract][Full Text] [Related]
5. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
[TBL] [Abstract][Full Text] [Related]
6. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Eur Neuropsychopharmacol; 1993 Jun; 3(2):111-6. PubMed ID: 8395919
[TBL] [Abstract][Full Text] [Related]
7. Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice.
Ballard TM; McAllister KH
Pharmacol Biochem Behav; 1999 Feb; 62(2):285-90. PubMed ID: 9972695
[TBL] [Abstract][Full Text] [Related]
8. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
[TBL] [Abstract][Full Text] [Related]
9. Influence of histamine, cimetidine and pyrilamine on naloxone-induced jumping in morphine-dependent mice.
Zarrindast MR; Assadi E; Oryan S; Torkaman-Boutorabi A; Sahebgharani M
Eur J Pharmacol; 2003 Jun; 471(2):105-12. PubMed ID: 12818697
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
Lizasoain I; Leza JC; Lorenzo P
Gen Pharmacol; 1991; 22(2):297-300. PubMed ID: 2055424
[TBL] [Abstract][Full Text] [Related]
11. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice.
Zarrindast MR; Mousa-Ahmadi E
Eur J Pharmacol; 1999 Sep; 381(2-3):129-33. PubMed ID: 10554880
[TBL] [Abstract][Full Text] [Related]
12. Phenothiazine-type antipsychotics may attenuate naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Wu SZ; Chen KT; Chen JY; Sung KC; Wang JJ; Liu KS; Chu CC
Acta Anaesthesiol Taiwan; 2012 Dec; 50(4):167-71. PubMed ID: 23385039
[TBL] [Abstract][Full Text] [Related]
13. Intracisternal administration of interleukin-1 beta attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
Katsumata S; Minami M; Nakagawa T; Satoh M
Eur J Pharmacol; 1995 May; 278(2):143-50. PubMed ID: 7671998
[TBL] [Abstract][Full Text] [Related]
14. Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice.
Patel D; Vishwakarma PK; Patel R; Jain NS
Behav Brain Res; 2021 Feb; 399():112997. PubMed ID: 33166570
[TBL] [Abstract][Full Text] [Related]
15. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
Fdez Espejo E; Cador M; Stinus L
Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine attenuated morphine withdrawal syndrome in the rat.
Charkhpour M; Jafari RM; Ghavimi H; Ghanbarzadeh S; Parvizpur A
Drug Res (Stuttg); 2014 Aug; 64(8):393-8. PubMed ID: 24265113
[TBL] [Abstract][Full Text] [Related]
17. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
19. Behavioral changes produced in the cat by acute and chronic morphine injection and naloxone precipitated withdrawal.
French ED; Vasquez SA; George R
Eur J Pharmacol; 1979 Aug; 57(4):387-97. PubMed ID: 573695
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Neurosci Lett; 1993 Nov; 162(1-2):97-100. PubMed ID: 7510058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
